Article Details

CytomX Therapeutics, Inc. (NASDAQ:CTMX) Given Average Rating of “Moderate Buy” by Brokerages

Retrieved on: 2025-03-10 09:19:27

Tags for this article:

Click the tags to see associated articles and topics

CytomX Therapeutics, Inc. (NASDAQ:CTMX) Given Average Rating of “Moderate Buy” by Brokerages. View article details on hiswai:

Excerpt

Schonfeld Strategic Advisors LLC now owns 1,380,800 shares of the biotechnology company's stock worth $1,422,000 after buying an additional ...

Article found on: reporter.am

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo